JW Therapeutics
Scope
Date
~
-
Mergers & AcquisitionsSamsung buys $2.3 bn Bioepis stake from Biogen to end partnership
Samsung Biologics Co. is acquiring a nearly 50% stake in a biosimilar joint venture with Biogen Inc. from the US biotechnology company for $2.3 bill...
Jan 28, 2022 (Gmt+09:00)
language -
PharmaceuticalsKorean pharma joins global race in RNA therapeutics development
The field of ribonucleic acid (RNA) therapeutics, once considered an unexplored area, is now the most coveted sector in the global biotech industry....
Jan 21, 2022 (Gmt+09:00)
-
BiotechJW Bioscience in pancreatic cancer biomarker deal with Immunovia
JW Bioscience Co., a subsidiary of South Korea’s JW Life Science Co., has signed a non-exclusive agreement to transfer its patented technology...
Sep 15, 2021 (Gmt+09:00)
language -
MedicineJW Pharm exports new antibiotic substance to US
JW Pharmaceutical Co. has become the first South Korean drug maker to develop the generic version of a next-generation antibiotic substance, the med...
Jun 10, 2021 (Gmt+09:00)
-
MedicineCelltrion, Mirae to take largest stake in UK biotech firm
South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...
Jun 07, 2021 (Gmt+09:00)
language -
Artificial intelligenceSamsung, Bayer join $90 mn investment in AI healthcare app Ada Health
Samsung Electronics Co. and Germany’s pharmaceutical giant Bayer AG have made a joint investment in the Berlin-based artificial intelligence (...
May 28, 2021 (Gmt+09:00)
